Nichi-Iko Pharmaceutical Co., Ltd. announced consolidated earnings results for the year ended March 31, 2021. For the year, the company reported revenue of JPY 188,218 million compared to JPY 190,076 million a year ago. Operating profit was JPY 107 million compared to JPY 2,873 million a year ago. Loss was JPY 4,273 million or JPY 65.28 per basic share compared to profit of JPY 4,917 million or JPY 80.42 per basic share a year ago.